arrow
D

Daniel C. Beachler

Carelon Research
H指数:21
被引数:2,253

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety monitoring of health outcomes following influenza vaccination during the 2023–2024 season among U.S. Commercially-insured individuals aged 6 months through 64 years: Self-controlled case series analyses

2023–2024流感季节美国商业保险人群中6个月至64岁个体接种流感疫苗后的健康结局安全性监测:自我对照病例系列分析

Vaccine
IF3.5
2025-08-210
PRE
Liver, renal, genitourinary and diabetic ketoacidosis risks among new users of empagliflozin versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: Post-authorization safety study based on multinational cohorts
2024-01-170
OA
Safety of the BNT162b2 COVID-19 Vaccine in Children Aged 5 to 17 Years
2023-07-0111
OA
Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting
2022-12-302
OAAI
Geographic heterogeneity in the prevalence of human papillomavirus in head and neck cancer
2017-02-14109
OAAI
Effect of HPV on head and neck cancer patient survival, by region and tumor site: A comparison of 1362 cases across three continents (vol 62, pg 20, 2016)
2017-02-010
OAAI